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Improving hindlimb locomotor function by Noninvasive AAV-mediated manipulations of
propriospinal neurons in mice with complete
spinal cord injury
Benedikt Brommer1,6, Miao He1,6 ✉, Zicong Zhang1, Zhiyun Yang1, Jessica C. Page 1, Junfeng Su1, Yu Zhang1,
Junjie Zhu 1, Emilia Gouy1, Jing Tang1, Philip Williams1,2, Wei Dai1, Qi Wang1, Ryan Solinsky3,4, Bo Chen5 ✉ &
Zhigang He 1 ✉

After complete spinal cord injuries (SCI), spinal segments below the lesion maintain intersegmental communication via the intraspinal propriospinal network. However, it is unknown
whether selective manipulation of these circuits can restore locomotor function in the
absence of brain-derived inputs. By taking advantage of the compromised blood-spinal cord
barrier following SCI, we optimized a set of procedures in which AAV9 vectors administered
via the tail vein efﬁciently transduce neurons in lesion-adjacent spinal segments after a
thoracic crush injury in adult mice. With this method, we used chemogenetic actuators to
alter the excitability of propriospinal neurons in the thoracic cord of the adult mice with a
complete thoracic crush injury. We showed that activating these thoracic neurons enables
consistent and signiﬁcant hindlimb stepping improvement, whereas direct manipulations of
the neurons in the lumbar spinal cord led to muscle spasms without meaningful locomotion.
Strikingly, manipulating either excitatory or inhibitory propriospinal neurons in the thoracic
levels leads to distinct behavioural outcomes, with preferential effects on standing or stepping, two key elements of the locomotor function. These results demonstrate a strategy of
engaging thoracic propriospinal neurons to improve hindlimb function and provide insights
into optimizing neuromodulation-based strategies for treating SCI.
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t is known that the spinal cord possesses intrinsic neural circuits, often referred to as central pattern generators (CPGs),
that are sufﬁcient to generate many types of behaviourally
important motor commands1,2. Yet the question remains as to
why such CPG networks do not mediate functional restoration in
patients and animal models of severe spinal cord injury (SCI). A
suggested culprit is the substantially reduced excitability of the
spinal network after injury3–6. Thus, a logical repair strategy is to
develop methods to re-engage CPGs for functional restoration7–9.
In intact animals, CPG neurons in the lumbar spinal cord receive
brain-derived commands and peripheral sensory afferent inputs,
as well as signals from intraspinal/propriospinal neurons that are
distributed throughout all spinal levels10–15. After a complete
injury at upper levels, lumbar CPG neurons are deprived of
descending inputs from the brain but are still directly or indirectly connected with both propriospinal networks and peripheral
sensory afferents below the lesion. Several methods, such as
epidural electrical stimulation and/or rehabilitative training, and
pharmacological treatments have been shown to confer improved
locomotor function in animal models and patients with severe
SCI8,16–18. However, the achieved recovery is variable, often
limited, and without clearly deﬁned functional mechanisms.
Thus, there is a pressing need to understand how such spinal
CPGs are regulated after losing supraspinal inputs and identify
more precise targets that mobilize local spinal circuitry, particularly for treatments like electrical stimulation.
In principle, lumbar CPG neurons and/or their remaining
inputs, both sensory afferents and propriospinal networks, could
be potential targets for re-activating CPGs for functional
restoration5,19. However, whether any of these components
underlie the functional outcomes of electrical stimulation and/or
rehabilitation training remains an intensively debated topic5,16,19.
In the case of propriospinal neurons, whose axons form intricate
networks among different spinal segments, several studies
demonstrate that they form indirect pathways relaying brainderived signals to the spinal cord in conditions of incomplete
SCI20–22. However, it is unknown whether these neurons, in the
absence of brain-derived commands, are sufﬁcient to initiate
behaviourally relevant activity patterns in lumbar CPGs.
To address these questions, we focused on adult mice with
complete crush injury at thoracic levels, as manipulating either
propriospinal neurons with descending projections or neurons in
the lumbar spinal cord could serve as a good starting point.
Different from the concentrated location of lumbar CPG neurons,
propriospinal neurons are widely dispersed at all spinal levels.
Thus, a technical challenge is how to efﬁciently target these
propriospinal neurons. Direct injection of viral vectors to the SCI
site has been used to express neurotrophic factors23,24. However,
such an invasive procedure needs multiple injections, has variable
efﬁciency, and could further traumatize the overlying structure of
the spine as well as the remaining spinal cord tissue adjacent to
the lesion site. On the other hand, following trauma to the spinal
cord, the blood-spinal cord barrier (BSCB) breaks down due to
vascular damage25 and potential secondary inﬂammation, thereby
remaining temporarily impaired. We reasoned that AAV transduction of the SCI penumbra would be possible through intravenous administration during the acute phases after injury. In this
study, we ﬁrst systematically analyzed the transduction efﬁciency
and the cellular tropism of ten different AAV serotypes after
intravenous injection at different time points post-SCI. We used
our optimized method to express chemogenetic actuators, either
the excitatory or inhibitory version of Designer Receptors
Exclusively Activated by Designer Drugs (DREADDs), in different populations of thoracic neurons around the lesion and
demonstrated that different manipulations led to strikingly distinct motor function improvements. Our results demonstrate the
2

feasibility of mobilizing the intrinsic lumbar neural circuitry for
functional restoration by propriospinal axon-assisted remote
control.
Results
Tail vein injected AAV2/9 efﬁciently transduces the neurons
around lesions in the thoracic spinal cord. We ﬁrst attempted to
develop a method to selectively target neurons, including descending projecting propriospinal neurons in the thoracic levels
around the lesion site. Since SCI leads to an acute breakdown of the
BSCB, we reasoned that intravenous administration of AAVs could
yield efﬁcient transduction of cells surrounding the lesion site
without surgical intervention. To determine which AAV serotypes
could best transduce cells around the lesion epicentre, we injected
8•1012 gc particles of AAV-CAG-H2B-GFP, packaged within different serotypes, into the tail vein of mice 3 h after a T8 complete
crush injury (Fig. 1a). CAG is a ubiquitously expressed promoter,
and H2B-GFP, a histone 2B-GFP fusion protein, is localized in the
nuclei of transduced cells, facilitating the assessment of transduction efﬁciency. We chose 3 h after injury to represent the earliest
clinically feasible time point post SCI for such a treatment. The
serotypes tested included 2/1, 2, 2/5, 2/6, 2/7, 2/8, 2/9, 2/10, retroAAV, and DJ. We found that serotypes 2, 2/5, and 2/6 showed
almost no expression; all other serotypes led to appreciable
transduction of cells restricted to the area adjacent to the lesions
examined at 14 days after injection (Fig. 1a, b). Among them,
serotypes 2/9 and 2/10 achieved the strongest expression across
approximately two spinal cord segments (Fig. 1a, b).
While the experiments above were performed with viral
injection at 3 h after injury, we next assessed the duration of
this time window for vein injected AAV vectors to cross the BSCB
and transduce cells around the lesion after injury. To do this, we
focused on AAV2/9, which is known to have limited ability of
crossing the BBB in the intact adults and AAV2/7 (Supplementary Fig. 1a). We injected H2B-GFP vectors of these serotypes
into the tail vein of mice at different time points (0 or 3 h, and 1,
3, or 7 days) post injury. As shown in Supplementary Fig. 1a–d,
GFP expression remained strong when tail vein injection was
performed 1 day after crush, but gradually reduced when injected
3 days after SCI and was barely detectable when introduced at
7 days after injury.
To characterize the tropism of tail-vein injected AAV-H2BGFP vectors in injured spinal cords, histological spinal cord
sections were immunostained with markers of individual cell
types and then subjected to a custom-made quantiﬁcation
algorithm (see Methods for details). AAV2/9 primarily transduced neurons followed by oligodendrocytes and astrocytes but
not pericytes (PDGFRβ), microglia/macrophages (CD68), or
endothelial cells (CD31) (Supplementary Fig. 1e–i).
To assess whether such transduced cells include propriospinal
neurons with descending projections, we co-injected AAV2/9Syn-H2B-GFP (to visualize the cell bodies of transduced neurons)
and AAV2/9-Syn-ChR2-tdTomato (to visualize both the axons
and cell bodies of transduced neurons, including propriospinal
axons) to the tail vein of adult mice at 3 h after injury. As shown
in Fig. 1c, the transduced neuronal somas (GFP+) are almost
exclusively localized in thoracic levels around the lesion site.
Importantly, numerous tdTomato+ axons were detected in the
lumbar spinal cord (Fig. 1e, f), suggesting efﬁcient labelling of
propriospinal neurons with descending projections to the lumbar
spinal cord.
DREADD-assisted activation of thoracic neurons leads to
hindlimb locomotor improvements after T8 complete crush
injury. With the AAV2/9-based system to target propriospinal
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Fig. 1 A screen for AAV serotypes that are able to cross blood spinal cord barrier and transduce cells around the lesion after spinal cord crush.
a Representative images of longitudinal sections of the thoracic spinal cord show transduced cells after tail vein injection of different serotypes of AAVs
expressing CAG-H2B-GFP at 3 h after T8 crush injury. Similar distributions were observed in all of 3 analysed mice for each AAV serotype. Scale bar:
1 mm. An asterisk represents lesion centre. b Quantiﬁcation of GFP expression along the longitudinal axis. Mean ± SD are indicated by line and shadow
with corresponding colours. a.u.: arbitrary unit. The ﬂuorescence intensities were normalized to that in AAV2/9 (n = 3 mice for each AAV serotype,
5 sections per mouse). c Representative image showing the expression of H2B-GFP (cell bodies only) in different spinal levels. Similar distributions
were observed in all of 3 analysed mice. Scale bar: 1 mm. d Magniﬁcation of the highlighted area one spinal segment away from the lesion (purple box
in (c)), indicating co-localization of H2B-GFP and NeuN. Scale bar: 100 µm. e Representative image showing the expression of ChR2-tdTomato
(cell bodies and axons) in different spinal levels. Similar distributions were observed in all of 3 analysed mice. Scale bar: 1 mm. f Cross section of the
lumbar spinal cord showing descending ChR2-tdTomato+ axons from thoracic propriospinal neurons. Similar distributions were observed in all of
3 analysed mice. Scale bar: 500 µm.
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and other neurons around the lesion site with high efﬁciency, we
then used this method to express chemogenetic actuators in these
neurons and examined the behavioural outcomes of altering their
excitability in mice with SCI. To do this, we focused on adult mice
with T8 complete crush injury, a surgical procedure that destroys
all neural tissues at the lesion level22,26,27. To further characterize
this injury model, we monitored serotonergic axons around the
lesion at different time points by immunohistochemistry with
antibodies against 5-HT (Supplementary Fig. 2), a surrogate
marker for completeness of injury. This method was used to label
all serotonergic axons, thus bypassing issues of partial labelling
observed by most tracing procedures28. As shown in the serial
section of a single mouse spinal cord, as well as quaniﬁcation of
those from different mice (Supplementary Fig. 2a, d), no 5-HT
axons could be detected beyond the lesion acutely after injury,
supporting the completeness of this injury model. However, at
8 weeks after injury, a few axons were seen at the spinal cord
within 1–2 mm distal to the lesion (Supplementary Fig. 2b, d),
consistent with previous studies showing spontaneous regrowth
of serotonergic axons28–30. Thus, we used this model to assess the
effects of manipulating propriospinal neurons on hindlimb motor
function in the absence of supraspinal inputs.
To alter neuronal excitability, we used chemogenetic actuators,
either activating hM3Dq or inhibiting hM4Di DREADDs31,
under control of human synapsin promoter (Syn) to drive
neuron-speciﬁc expression. Wild-type adult mice were subjected
to a T8 complete crush injury followed by a tail vein injection of
AAV2/9-Syn-hM3Dq-mCherry or its control (AAV2/9-SynmCherry) 3 h after injury (Fig. 2a). Hindlimb locomotor
performance was assessed by the Basso Mouse Scale (BMS), an
established open-ﬁeld locomotion test with scores ranging from 0
(no movement of hindlimbs, complete paralysis) to 9 (coordinated plantar stepping in intact mice)32. As shown in Fig. 2b, this
injury caused hindlimb paralysis in all mice (no hindlimb
movement, BMS score at 0), with limited spontaneous recovery
that plateaued at paresis (only isolated ankle movements, average
BMS score at 1). None of these injured mice displayed any weight
support or stepping for up to 20 weeks after injury (Fig. 2b).
To assess the effects of activating the neurons expressing
hM3Dq, we treated the mice with clozapine-N-oxide (CNO), a
ligand for DREADDs, every 2 weeks after injury (Fig. 2b). In all
tested time points, mice with control virus had no improvements
after CNO treatment, but the mice expressing activating hM3Dq
exhibited signiﬁcantly improved hindlimb locomotor function, i.e.,
hindlimb plantar placement or dorsal stepping with an average
BMS score of 3 (Fig. 2b, Supplementary Video 1). At 1 h after CNO
treatment, a majority of hM3Dq-expressing mice (92%) regained
signiﬁcant weight-bearing dorsal or plantar stepping capabilities,
while a small portion (8%) only achieved plantar placement of the
hindlimbs (Supplementary Fig. 3b). The extent of improved
functional performance depended on the timing after CNO
administration (Supplementary Fig. 3a, Supplementary Video 1),
likely reﬂecting the clearance of CNO from circulation. Detailed
hindlimb kinematics revealed the following major improvements:
(1) a change from dragging ﬂaccid hindlimbs to a standing pose
(Fig. 2c); (2) increased weight support (increased iliac crest height,
Fig. 2c, f); and (3) regained hindlimb stepping ability indicated by
foot/toe lifting height (Fig. 2c, g), ankle range of motion
(Supplementary Fig. 3g), and the amplitudes of hindlimb iliac
crest height (Supplementary Fig. 3d). Importantly, the hindlimb of
these treated mice exhibited similar cycle duration and stance/
swing ratio as intact mice (Fig. 2d, e) and stepping frequency as
their forelimb (Supplementary Fig. 3h). Although alternate
stepping of hindlimbs was observed in these CNO-treated mice,
de-couplings between steps during free walking prevented accurate
quantiﬁcation of interlimb coordination. Taken together, these
4

results suggest that enhancing excitation of neurons in the spinal
thoracic levels enabled the completely paralyzed mice to perform
hindlimb stepping with body weight support.
On the other hand, although many neurons rostral to the
lesion also expressed hM3Dq, we did not observe detectable
behavioural differences in their forelimb upon CNO treatment
(Supplementary Fig. 3i, j). Consistent with improved hindlimb
stepping ability, EMG recordings indicate alternate ﬁring of the
ankle ﬂexor tibialis anterior muscle (TA) and the extensor
gastrocnemius soleus muscle (GS). On the other hand, the
proximal joints and their muscles, such as knee extensor vastus
lateralis (VL) and ﬂexor ST muscle, were also recruited during
walking, but with much lesser extent (Supplementary Fig. 4a, b).
Together, our data are indicating that CNO-treated mice
exhibited hindlimb movement that is mainly driven by the ankle
joint. The movements of other proximal joints might be
associated with passive dragging. Remarkably, such improvements were still triggered by CNO at 10 or 20 weeks after injury
(Fig. 2b), suggesting the efﬁcacy of manipulating the excitability
of thoracic neurons in both acute and chronic SCI models.
At the end of the experiments, we veriﬁed the complete injury
by immunohistochemistry with anti-5-HT antibody on transverse
sections at T10 and L2 (Supplementary Fig. 5a, b). With this tail
vein injection procedure, numerous mCherry+ axons, but not
cell bodies, were seen in the lumbar spinal cord, consistent with
the efﬁcient labelling of descending-projecting propriospinal
neurons (Supplementary Fig. 4c). Thus, these results suggest that
upon CNO treatment, activation of T8-13 neurons could
indirectly enhance the overall excitatibility of lumbar spinal cord
through propriospinal circuits and facilitate hindlimb locomotion. In support of this, we found that hindlimb responses to
noxious stimuli were partially recovered following CNO application (Supplementary Fig. 4d, e).
While these experiments involve the activation of thoracic
neurons, we also examined the outcomes of inhibiting these
neurons. As expected, injured mice expressing the inhibitory
hM4Di-DREADD in thoracic neurons failed to improve behavioural outcomes upon the same CNO treatment (Supplementary
Fig. 4f). Thus, these results suggest that activating the thoracic
neurons, including descending propriospinal neurons, allows
mice with nearly complete paralysis to achieve signiﬁcant
hindlimb locomotor function.
Activating excitatory neurons in the thoracic spinal cord preferentially improves standing ability after T8 crush injury.
Since propriospinal neurons could physiologically act as either
excitatory or inhibitory drivers13,14,33, we next assessed whether
manipulating each of these populations separately might give rise
to different behavioural outcomes. Thus, we ﬁrst examined the
effects of selective activation of the excitatory population by
utilizing Vglut2-Cre transgenic mice, which express Cre in excitatory spinal neurons34. Vglut2-Cre mice received tail vein
injections of AAV2/9-Syn-FLEX-hM3Dq-mCherry at 3 h after T8
crush injury and were then subjected to locomotor assessments
before and after CNO treatment at 4 weeks after injury (Fig. 3a).
Before CNO treatment, the mice had paralysis or paresis (BMS
score of 0–1). However, at all tested concentrations of CNO
(0.001–1 mg/kg), the hind limbs of vGlut2-Cre mice adopted a
ﬂexed position where the plantar paw surface gently draged
across the ground surface, with or without reﬂexive-like stepping,
with BMS scores of 3 (Fig. 3b, Supplementary Video 2)32. Even
after lower dose of CNO treatment (0.01 mg/kg), their hindlimbs,
in contrast to their forelimbs, only occasionally stepped, and had
predominant “stance” with rare swing phases (Fig. 3c, d), spasmlike rigid distal joints, and limited foot ﬂexion (toe-dragging)
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Fig. 2 hM3Dq-assisted activation of thoracic neurons elicits locomotion behaviour after T8 crush. a Experimental schematic. After a T8 crush injury,
wild type (WT) mice received a tail vein injection of AAV2/9-Syn-hM3Dq-mCherry or control virus (AAV2/9-Syn-mCherry) and their locomotion
behaviour was measured upon CNO administration every 2 weeks after injury. b BMS scores of injured mice with AAVs expressing hM3Dq-mCherry (left)
or control mCherry (right) at indicated time points, before and 1 h after administration of 1 mg/kg CNO. hM3Dq-mCherry group: n = 7; Control group: n =
5. Data shown as mean ± SD (and also for other panels). Factorial Repeated Measures ANOVA with 2 within-subjects factors, followed by two-tailed
paired t test at each time point. ns: no statistical difference, **p = 0.0090 (2 weeks); 0.0081 (4 weeks); 0.0012 (8 weeks); 0.0029 (10 weeks), ***p <
0.0001 (6 weeks, 20 weeks). c Stickviews of kinematic hindlimb analysis of intact mouse and mouse with hM3Dq expression before and after CNO
injection (1 mg/kg) at 4 weeks after injury. The phases of dragging, stance, or swing were marked in indicated colours. Cycle duration (d) and swing/
stance ratio (e) of intact mice and spinal cord injured mice with hM3Dq expression. Injured mice expressing hM3Dq dragged before CNO treatment, but
had similar stance/swing phase distributions as intact mice (Bar chart) after CNO treatment. Two tailed paired t test for within-group comparison (#) and
Wilcoxon rank sum for between-group comparison (*). **p = 0.0022 (hM3Dq); 0.0043 (hM3Dq CNO) and ###p < 0.001. Quantiﬁcation of the maximum
iliac crest heights (f) and the maximum toe heights (g). One-Way ANOVA with Tukey’s post test for between-group (*) and two tailed paired t tests for
within-group (#) comparsion. ***p < 0.001; **p = 0.0039; ##p = 0.0040 (f); ***p < 0.001; #p = 0.0166. For (d)–(g), n = 6 for each group.

(Fig. 3c and Supplementary Video 2). As a result, the hindlimb
stepping frequency was substantially lower than that of their
forelimbs, with a ratio of 1:6.7 (Supplementary Fig. 6a).
Furthermore, these mice had signiﬁcantly increased iliac crest
heights (Fig. 3e). However, compared with intact mice, these mice

showed limited toe/foot lifting and hindlimb joints rotation
capability (Fig. 3f, Supplementary Fig. 6c–e), suggesting limited
stepping improvements. It is noticeable that at higher doses of
CNO (0.1–1 mg/kg) treated mice developed rapid and repetitive
foot oscillations, likely signs of spasms (muscles jerks or repeated
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twitching) (Supplementary Fig. 6f and Supplementary Video 2).
Importantly, similar results were also obtained in mice with
delayed tail vein injections (1 day after injury) of AAV2/9-SynFLEX-hM3Dq-mCherry, though the effect was less pronounced
(Supplementary Fig. 6g), further substantiating the effects of
manipulating these thoracic neurons on hindlimb locomotor
function.
In addition to verifying no spared serotonergic axons remained
in the lumbar levels in mice with a T8 crush injury
(Supplementary Fig. 5), histological analysis indicated that these
6

descending-projecting mCherry+ neurons were mainly located in
thoracic levels (T8-T12), but barely in the lumbar levels if at all
(Supplementary Fig. 6h). At lumbar spinal cord levels, descending
axons project widely, including around the dorso-lateral cord, the
medial cord where most premotor neurons are located13,35, and
ventral horn where the majority of motor neurons reside (Fig. 3g,
h). Most striking is the bundle in the dorso-lateral spinal cord,
reminiscent of the “stepping strip” described by Kazennikov et al.
in cats36. Thus, these excitatory descending projections may
directly or indirectly engage motor neurons. Taken together, our
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Fig. 3 Activation of thoracic excitatory neurons improves standing but only minimal stepping in mice with T8 crush injury. a Experimental schematic.
After a T8 crush injury, Vglut2-Cre mice received a tail vein injection of AAV2/9-Syn-FLEX-hM3Dq-mCherry and were then subjected to behavioural
assessments at indicated time points. b BMS scores of Vglut2 mice expressing excitatory hM3Dq in thoracic neurons before and 1 h after CNO at different
doses (n = 5). Data shown as mean ± SD (also for other panels in this ﬁgure). Two tailed paired t test; **p = 0.010 (1 mg/kg); 0.002 (0.1 mg/kg); 0.0013
(0.01 mg/kg); *p = 0.0132 (0.001 mg/kg). c Stickviews of kinematic analysis of intact mice and Vglut2 mice expressing excitatory hM3Dq before and after
CNO (0.01 mg/kg). The phases of dragging, stance, or swing were marked in indicated colours. Data from intact mice are replotted from Fig. 2c for
comparison. d Duration of swing, stance and dragging phases of different groups of mice with CNO (0.01 mg/kg). Data from intact mice are replotted
from Fig. 2e for comparison. Two tailed sign test was used for within-group comparison (#) and Wilcoxon rank sum was used for between-group
comparison (*). ***/###p < 0.001, n = 6 for each group. Quantiﬁcation of the maximum iliac crest heights (e) and maximum toe heights (f). Two tailed
paired t test for within group comparison (#) and 2 sample t test for between group comparison (*). **p = 0.0019; ##p = 0.0078, ***p < 0.001 and n.s. p =
0.5001. n = 6 (intact) and n = 8 (hM3Dq). Data from intact mice are replotted from Fig. 2f, g for comparison. A representative mCherry image (g) and
average density plot (h) of an L2 transverse section showing the distribution of descending projection axons in the lumbar spinal cord of injured Vglut2-Cre
mice with injection of AAV2/9-Syn-FLEX-hM3Dq-mCherry. n = 3 mice, 3–4 sections per mouse. Scale bar: 250 µm.

results show that recruiting excitatory neurons in the thoracic
levels leads to the recovery of signiﬁcant weight-bearing capacity
but limited stepping ability.
Inhibiting inhibitory neurons in the thoracic spinal cord preferentially promotes stepping in mice with T8 crush injury.
Next, we tested if silencing inhibitory neurons in thoracic levels
would mirror the effects seen after activating excitatory neurons.
To do this, Vgat-Cre transgenic mice, labelling inhibitory neurons34, received tail vein injection of AAV2/9-Syn-FLEX-hM4DimCherry at 3 h after complete spinal cord crush (Fig. 4a). Since
CNO has a low binding afﬁnity for hM4Di, higher CNO concentrations than for hM3Dq experiments were administrated.
Upon CNO treatment with 5 mg/kg at either 4 or 8 weeks after
injury, the majority of mice achieved hindlimb stepping ability
with an average BMS score of 3 (Fig. 4b–d, Supplementary
Fig. 7a, Supplementary Video 3). Consistently, these mice had
improved toe lifting and hindlimb joints (especially ankle joint)
rotation (Fig. 4f, and Supplementary Fig. 7c–e), and iliac crest
height amplitude (Supplementary Fig. 7b), to an extent similar to
that seen in intact mice. However, the same mice displayed only
mild improvement in body weight support (Fig. 4e), consistent
with the observations that they largely failed to elevate their
trunks or prevent knee striking with the ground (Supplementary
Video 3). On the other hand, in contrast to the limb/muscle
spasms observed with activation of excitatory neurons at higher
CNO concentrations, no spastic events were observed in these
mice with all doses of CNO tested (up to 10 mg/kg).
As expected, we did not observe any spared axons in the
lumbar level of these crushed mice (Supplementary Fig. 5).
Additional histological analysis indicated that in contrast to
excitatory propriospinal neurons, axons from the inhibitory
descending-projecting neurons mainly distribute in the intermediate and dorsal spinal cord close to the central canal (Fig. 4g,
h). Interestingly, the territory of such inhibitory neurons are
largely complementary to those of excitatory propriospinal axons,
i.e., avoiding the ventral zone or the entire dorsal horn (compare
to Fig. 3g, h). Taken together, these results suggest that excitatory
and inhibitory propriospinal neurons project to different regions
of the lumbar spinal cord and thus impact different aspects of
hindlimb locomotion. Speciﬁcally, while silencing inhibitory
neurons mainly improves hindlimb stepping frequency, primarily
due to ankle ﬂexion, activating excitatory projecting propriospinal
neurons leads to spasm-like episodes (muscle spasms) with
weight-bearing plantar foot placement but limited stepping.
Activation of lumbar-projecting thoracic propriospinal neurons is sufﬁcient for eliciting locomotor behavioural after
injury. The experiments described above relied on non-selective

manipulation of thoracic neurons, including propriospinal neurons projecting to the lumbar spinal cord and other spinal segments. We next examined whether selective manipulation of
propriospinal neurons that project axons to the lumbar cord is
sufﬁcient to mediate functional performance. To do this, we
modiﬁed our experimental procedure by injecting retro-AAV-Cre
into the lumbar spinal cord 7–10 days after T8 crush and tail vein
injection of AAV2/9-Syn-FLEX-hM3Dq-mCherry 3 hr after
injury (Fig. 5a). As retro-AAVs can efﬁciently transduce neurons
via their axonal terminals37, this intersectional procedure led to
the expression of hM3Dq-mCherry in thoracic propriospinal
neurons that project into the lumbar cord (Supplementary Fig. 8).
Before CNO application, all mice were paralyzed with an average
BMS score below 1. However, CNO treatment led to signiﬁcant
behavioural improvements (with an average BMS score of 3)
(Fig. 5b, c), to extents similar to non-selective hM3Dq-mCherry
expression in wild-type mice (Fig. 2). Mice displayed signiﬁcant
improvements in body weight support, as shown by increased
heights of the iliac crest and hip joints after CNO treatment
(Fig. 5d), as well as improved stepping ability as indicated by
increased toe height (Fig. 5e).

Manipulating neurons in lumbar spinal cord triggers severe
spasms without locomotor function after T8 complete crush
injury. The experiments above demonstrate that manipulating
thoracic propriospinal neurons impacted neuronal circuits in the
lumbar spinal cord for functional improvement, presumably by
indirectly driving local lumbar circuits like the CPG or lumbar
motor pools. We next asked if directly manipulating neurons in
the lumbar spinal cord might have similar behavioural outcomes.
For this, we optimized a protocol for stereotaxic injection of
AAVs to the lumbar spinal cord (Supplementary Fig. 9a), which
led to mCherry expression across most of the lumbar cord
(Supplementary Fig. 9b). In order to probe the contribution of
different neuronal populations, we injected AAV2/1-SynhM3Dq-mCherry to the lumbar cord of wild-type mice (for
activating all neurons), AAV2/1-Syn-FLEX-hM3Dq-mCherry to
that of Vglut2-Cre mice (for activating excitatory neurons), and
AAV2/1-Syn-FLEX-hM4Di-mCherry to that of Vgat-Cre mice
(for inhibiting inhibitory neurons) (Supplementary Fig. 9a). After
lumbar injection, overground locomotor behaviour was monitored for 7–10 days. Only mice showing no observable motor
deﬁcits were used for T8 crush injury and behavioural assessments. When tested with CNO treatment in the weeks to months
post-injury, no meaningful functional locomotion was observed
in any group. Instead, all groups exhibited strong and frequent
muscle spasms, albeit with different patterns (Supplementary
Fig. 9c, d Supplementary Video 4). By using the Penn spasm
frequency scale38, we found that all mice reached a score of 4 out
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of 4, with more than 10 spontaneous spasms/hour (Supplementary Fig. 9e).
Interestingly, different patterns of muscle spasms were
observed in each group (Supplementary Fig. 9c). Lumbar
expression of hM3Dq in wild-type mice led to spasms of the
legs, most pronounced in hip ﬂexors (likely gluteus medius,
Supplementary Fig. 9d), with an overall stiffness and forward/
inward stretching of the hindlimbs. This phenotype was so
8

pronounced that mice almost always fell towards one side of their
body and dragged their extended hindlimbs on the other.
Selective expression of hM3Dq in Vglut2-Cre mice led to similar
observations, but these mice had episodes of random spasms. In
general, these mice often stood still, seemingly unwilling to walk,
during which no leg spasms were observed. However, when mice
were lifted up during such periods, they showed tremor-like
shaking of their paws with spontaneous bursts of leg spasms.
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Fig. 4 Inhibition of thoracic inhibitory neurons preferentially improve stepping ability in mice after T8 crush. a Experimental schematic. After a T8 crush
injury, Vgat-Cre mice received a tail vein injection of AAV2/9-Syn-FLEX-hM4Di-mCherry. b BMS scores of Vgat-Cre mice with hM4Di expression in
thoracic neurons before and 1 h after the application of 5 mg/kg CNO at 4 and 8 weeks past SCI. Data shown as mean ± SD (also for other panels in this
ﬁgure). Two tailed paired t test. ***p < 0.0001 (4 weeks); **p = 0.0020 (8 weeks). n = 10 (4 weeks) and n = 6 (8 weeks). c Stickviews of detailed
kinematic analysis in intact mice and Vgat mice with hM4Di expression in thoracic neurons before and 1 h after CNO (5 mg/kg). The phases of dragging,
stance, or swing were marked in indicated colours. Data from intact mice are replotted from Fig. 2c for comparison. d Duration of swing, stance, and
dragging phases of different groups of mice. Data from intact mice are replotted from Fig. 2e for comparison. Two tailed sign test was used for within-group
comparison (#) and Wilcoxon rank sum was used for between-group comparison (*) n = 6 (intact group) and n = 8 (SCI group). ***p < 0.001.
Quantiﬁcation of maximum iliac crest heights (e) and maximum toe heights (f). Two tailed paired t test for within-group comparison (#) and 2 sample
ttest for between-group comparison (*). #p = 0.0045 (e); 0.0191 (f) and ***p < 0.0001. n = 6 (intact) and n = 8 (hM4Di). Data from intact mice are
replotted from Fig. 2f, g for comparison. A representative mCherry image (g) and average density plot (h) of an L2 transverse section showing the
distribution of descending projection axons in the lumbar spinal cord in injured Vgat-Cre mice with a tail vein injection of AAV2/9-Syn-FLEX-ChR2mCherry. n = 3 mice, 3–4 sections per mouse. Scale bar: 250 µm.

Fig. 5 Activation of propriospinal neurons that project from thoracic to lumbar levels elicits locomotor behavioural recovery after T8 crush.
a Experimental schematic of the intersectional strategy of limiting hM3Dq expression to propriospinal neurons projecting to lumbar spinal cord.
b Stickviews of kinematic analysis of intact mice and injured mice with targeted expression of hM3Dq in long-projecting neurons before and during CNO
(1 mg/kg). The phases of dragging, stance, or swing were marked in indicated colours. Data from intact mice are replotted from Fig. 2c for comparison.
c BMS scores of mice with targeted expression of hM3Dq in long-projecting neurons at 4 and 8 weeks after injury, before and 1 h after application of 1 mg/
kg CNO. Data shown as mean ± SD. Two tailed paired t test. **p = 0.0002 (4 weeks) ***p < 0.0001 (8 weeks). n = 7 (4 weeks) and n = 3 (8 weeks).
Quantiﬁcation of the maximum iliac crest heights (d) and the maximum toe height (e). n = 6 (intact) and n = 5 (hM3Dq). Data from intact mice are
replotted from Fig. 2e, f for comparison. Shown are means ± SD. Two tailed paired t test for within-group comparison (#) and two sample t test for
between-group comparison (*). ##p = 0.0030, **p = 0.0003, ***p < 0.001 and #p = 0.0017.

On the other hand, in all Vgat-Cre mice with hM4Di expression,
we observed extension of the hindlimbs behind the body and
continuous bilateral spasms.
EMG recordings revealed random ﬁring of all muscle groups
tested, but with some differences: (1) in both wild-type and
Vglut2-Cre mice with hM3Dq expression, strong activation of hip

extensors was observed, and (2) in Vgat-Cre mice with hM4Di
expression, non-stopping co-activation of ankle extensor and
ﬂexor muscles occurred (Supplementary Fig. 9d, f). Such different
forms of spasms were unlikely due to the variation in surgical
injection, as the same procedure was used in all mice (one
example of viral mediated tdTomato expression in lumbar spinal
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cord is shown in Supplementary Fig. 9b), and relatively consistent
behaviour was observed in all mice of each group. Together, our
results suggest that direct manipulation of lumbar spinal neurons
failed to lead to patterned activation with meaningful behavioural
improvements.
Discussion
In this study, we optimized a non-invasive intravenous injection
method that can efﬁciently target neurons, and other cell types,
extending at and adjacent to a spinal cord lesion over a clinically
relevant time frame. With this procedure, we introduced chemogenetic DREADDs to thoracic neurons in mice with a complete
thoracic SCI and demonstrated that modulating their excitability
triggered consistent and signiﬁcant hindlimb stepping, a movement that primarily recruits ankle joint ﬂexion and extension.
Intriguingly, distinct behavioural outcomes were observed after
altering excitatory or inhibitory propriospinal neuron activity in
the thoracic spinal cord, with preferential improvements on
standing when activating excitatory neurons or stepping when
inhibiting inhibitory neurons.
Efﬁcient AAV delivery to the SCI epicentre. Neurons and glial
cells around the SCI epicentre are most affected and should be a
primary target of therapeutic interventions. However, there is no
efﬁcient method of targeting these cells efﬁciently and selectively.
Taking advantage of transiently compromised BSCB after injury,
we demonstrated that AAV2/9 vectors, if injected within three
days after SCI, are able to transduce the majority of cells around
the lesion site. Interestingly, not all serotypes of AAV vectors
could do the same, as some, such as AAV2/5 and AAV2/6,
transduced few cells even with similar numbers of viral particles
injected. Thus, it is unlikely that the blood spinal cord barrier is
totally opened to allow all types of AAVs to enter the spinal cord
even after injury. Such variation in AAV serotype penetration
might be relevant to their binding properties with cells in the
BSCB. In particular, AAV2/9 was shown to possess some capacity
of crossing the blood brain barrier (BBB), most noticeably in
neonatal ages39. Alternatively, some serotypes could have tropisms for cells in other organs, which would reduce their likelihood
of binding to cells of the BBB.
Within the CNS, variance in cellular tropism between different
AAV serotypes has been observed after direct injections40,41 or
systemic delivery42. Surprisingly, we did not see major differences
in cellular tropism within the spinal cord after BSCB mediated
crossing of any tested AAV serotypes. This might be due to the
unique delivery method. It is also possible, that the use of H2BGFP in our experiments allowed for more sensitive and
unambiguous detection of positive cells. Indeed, the distribution
of cellular tropism among most of our serotypes was similar to
those reported for PHP.B after tail vein injection in which H2BGFP was used as a reporter43.
To speciﬁcally deliver target genes to CNS cell types whose
infection is desired, one strategy is to use promoters speciﬁc for
these cells, like glial ﬁbrillary acidic protein promotor for limiting
expression to astrocytes or synapsin promotor for exclusive
expression in neurons. This makes intravenous injection of AAVs
after SCI a convenient method to express desired genes broadly
throughout the injury site while preventing gene expression in
non-injured CNS areas or non-CNS organs.
Propriospinal pathways as a target for promoting functional
recovery. For function restoration in both animal models and
human patients with SCI, a key question is how to activate the
intrinsic neuronal circuits within the spinal cord. In SCI patients
electrical stimulation has been used successfully to restore
10

locomotor function3,4,44. Despite these exciting clinical successes,
the mechanisms underlying such electrical neuromodulation are
still under debate16,45.
Currently, proposed targets include axons in the dorsal roots,
longitudinal spinal ﬁbres of the posterior column, and propriospinal networks, among others. Because of a lack of direct
assessments of these neuronal circuits, most efforts in this
direction have relied on computational methods46,47. In assessing
the behavioural outcomes when manipulating different cohorts of
neurons, our results revealed strikingly diverse outcomes between
lumbar-projecting thoracic proprospinal neurons (remote control) and local neuronal networks in the lumbar spinal cord
(direct control). Engagement of such remote control resulted in
advantageous patterned activity with functional stepping recovery, while direct control lead to unwanted hindlimb spasms.
Thus, our results point to these neurons as potentially powerful
targets for activating lumbar CPGs and triggering behaviourally
relevant activity patterns. In addition to assessing the engagement
of these long-projecting propriospinal pathways by electrical
stimulation, future studies should optimize such protocols to
recruit different remote control pathways for maximizing
functional recovery.
Unique projection patterns and function of excitatory and
inhibitory propriospinal projections. Maintaining precise excitatory/inhibitory electrochemical balance within neuronal networks is essential for all types of behaviour. This is largely
achieved by dynamic activation of excitatory and inhibitory
neurons. Interestingly, we found that activating excitatory propriospinal neurons allowed paralyzed mice to stand, but inhibiting inhibitory neurons preferentially promotes the recovery of
stepping capacity. Furthermore, their descending axons project
and terminate in different yet complementary regions of the
lumbar spinal cord. Excitatory axons terminate in most spinal
areas (excluding dorsal horn) with two prominent concentrations
in ventro-medial and dorso-lateral spinal cord, while inhibitory
axons are seen around the central canal, in particular the dorsomedial regions. Because spinal motor neurons are located in the
ventral spinal cord, it is conceivable that excitatory inputs recruit
motor neurons directly and their pre-motor neurons for coordinated muscle activation (muscle strength). On the other hand, the
dorso-medial spinal cord hosts many commissural neurons with
their projections to their contralateral cord48. Thus, inhibitory
propriospinal inputs may be more suited for bilateral coordination required for stepping. This may also explain the spasms
associated with activation of excitatory propriospinal neurons but
not inhibition of inhibitory neurons.
The striking axonal bundles from the excitatory descending
axons were observed in the dorso-lateral funiculus, which might
be relevant to the “stepping strip” described by Kazennikov
et al.34. In their studies, they showed that in mesencephalic cats
micro-stimulation of the dorso-lateral funiculus is sufﬁcient to
elicit hindlimb stepping36,49. In addition, Chung et al. also
reported that many propriospinal axons project into the dorsal
funiculi or dorso-lateral funiculus49–51. It would be interesting
(meaningful) to discern the physiological function and translational potential of such longitudinal projections.
Intriguingly, previous studies showed that standing or stepping
could be improved in task-speciﬁc manner in spinally transected
cat52–54. When trained speciﬁcally to stand, these cats could stand
but not walk. On the other hand, when these animals were trained
to walk, they could not stand52,53. However, relevant neural
substrates for supporting standing or stepping remain unknown.
Based on our results, it would be interesting to assess whether taskspeciﬁc training may preferentially recruit excitatory or inhibitory
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propriospinal neurons and if training and our manipulations could
be combined for better rehabilitative outcomes.
In conclusion, in a complete thoracic SCI model, we
demonstrated the feasibility of achieving functional locomotion
by manipulating propriospinal neurons in the thoracic levels.
Future studies will investigate whether this approach could be
combined with regenerative strategies such as axon regeneration55–57 and stem cell grafting58 to enhance both automatic and
intentional functional recovery in the conditions of complete or
incomplete SCI. As AAV2/9 is increasingly used for gene
therapy59,60, it is conceivable that technology like DREADDassisted neuronal mondulation could be useful for functional
restoration in clinical settings.
Methods
Mouse strains. Wild-type C57BL/6 mice were purchased from Charles River
Laboratories. Vglut2-Cre and Vgat-Cre mice were obtained from Jackson
Laboratory (Jax stock # 016963 and 028862, respectively). Surgeries were conducted on adult female mice (18–21 g) at the age of 8–10 weeks. All experiments
were performed in compliance with protocols approved by the IACUC at Boston
Children’s Hospital. Mice were given ad libitum access to food and water, and
housed in cages under 12 h day/night cycles with bedding changed frequently.
Mice were not permitted to breed before or during their inclusion in in vivo
experiments.
Plasmids and viruses. pAAV-Syn-GFP was a gift from Edward Boyden (Addgene
plasmid # 58867), AAV-FLEX-ChR2-tdtomato was a gift from Scott Sternson61
(Addgene plasmid # 18917), pAAV-hSyn-hChR2(H134R)-mCherry was a gift from
Karl Deisseroth (Addgene plasmid # 26976), and pAAV-hSyn-DIO-hM3D(Gq)mCherry, pAAV-hSyn-DIO-hM4D(Gi)-mCherry, and pAAV-hSyn-DIO-mCherry
were a gift from Bryan Roth62 (Addgene plasmid # 44361, 44362 and 50459).
pAAV-CAG-FLEX-H2B-GFP was purchased from Vigenbio. pAAV-Syn-mCherry
and pAAV-Cre was constructed as described earlier22,63. pAAV-CAG-H2B-GFP
was constructed by replacing GFP in pAAV-CAG-GFP (developed by Z. He lab)
with H2B-GFP (from Addgene plasmid # 11680). All plasmids were packaged into
AAVs by the Boston Children’s Hospital Viral Core. These AAV vectors include:
AAV-2/1, 2, 2/5, 2/6, 2/7, 2/8, 2/9, 2/10, retro-AAV, and DJ-CAG-H2B-GFP,
AAV2/9-Syn-H2B-GFP, AAV2/9-CAG-FLEX-H2B-GFP, AAV2/9-Syn-hM3DqmCherry, AAV2/9-Syn-ChR2-tdTomato, AAV2/9-Syn-FLEX-hM3Dq-mCherry,
AAV2/9-Syn-FLEX-hM4Di-mCherry, Retro-AAV-Cre, AAV2/1-Syn-hM3DqmCherry, AAV2/1-Syn-FLEX-hM3Dq-mCherry, and AAV2/1-Syn-FLEX-hM4DimCherry.
Surgeries
T8 crush injury. The procedure is similar to what described previously26,27. Mice
received pain medication (buprenorphine, 0.05 mg/kg) 1 h before surgery and were
anaesthetised with ketamine/xylazine (100/10 mg/kg). To prevent xerophthalmia
during anaesthesia, both eyes were covered with eye lube. The back fur was shaved,
the skin overlying the vertebral column was incised, and the muscles were detached
from the vertebra. A single-level bilaminectomy (complete removal of the dorsal
arch of the vertebrae: processus spinosus and bilateral lamina arcus vertebrae) was
then performed to expose the spinal cord at the level of T8. After opening the
dura mater, the spinal cord was crushed with ﬁne forceps (Fine Science Tools),
resulting in a complete injury. The wound was rinsed with normal saline and
closed in layers. After SCI, 1 ml of saline was injected subcutaneously. Mice were
kept in 25 °C incubator for less than 48 h. Postoperative care comprised of
analgesic treatment for three days following SCI and manual bladder compression
twice daily. Any urinary infection was treated with an antibiotic therapy (Baytril,
10 mg/kg, for 7 days). The body weight of each mouse was measured weekly and
any presenting more than a 15% decrease in body weight was sacriﬁced.
Tail vein injection. For tail vein injections mice were anesthetized with isoﬂurane
(1.5–2% in 2:3 O2/N2O, inhaled). The tail was washed with 70% ethanol and 200 µL
virus diluted in saline were injected into the tail vein through a syringe with a 30 G
needle. For serotype analysis (Figs. 1A and S1), we used 8•10^12 gc per mouse
(200 µL of 4•10^13 gc/mL) of virus titered with ITR primer (Supplementary
Table 1). For AAV2 where such high titre can not be produced, we used the highest
reasonably available titre of 8•10^11 gc per mouse. For functional studies, we used
virus titered with WPRE. Since these primers generally result in an approximately
40-fold lower titre, we injected 200 µL of 1*10^12 gc/mL, resulting in 2•10^11 gc/
mouse.
Lumbar spinal cord injection. For retrograde tracing experiments, lumbar spinal
cord injection was conducted 7–10 days after both the T8 crush and subsequent tail
vein injection. As described previously22,64, retro-AAV was injected into left and
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right lumbar spinal cord from segments L2-L4. Injection coordinates were 0.5 mm
lateral of the midline. 3 injection sites were separated 1 mm away, and at each site
2 injections were performed at 2 different depths, 0.6 mm and 1.2 mm (in total 6
injections per side, 100 nl per injection). This procedure was also used for the
experiments in Fig. 5 where AAV vectors were injected into the lumbar spinal cord
7–10 days before T8 crush.
CNO injection. In mice that received DREADD-expressing AAVs, injections of
clozapine-N-oxide (CNO, BML-NS105, Enzo Life Sciences Inc) were given i.p. at a
concentration of 1 mg/kg for hM3Dq (0.001–1 mg/kg in Vglut2 mice as indicated
in Figs. 3) and 5 mg/kg for hM4Di and control virus, at indicated time points.
Histology. Anesthetized mice were transcardially perfused with 4% paraformaldehyde (PFA). Dissected spinal cords were post-ﬁxed in 4% PFA overnight,
and then immersed in 30% sucrose solutions at least two days before embedding
and snap-freezing in OCT. 20 µm thick sections were cut for cross sections and
taken up on coated glass slides and 40 µm sections were cut for free ﬂoating and
kept in PBS at 4 °C. For serial sections, the spinal cord segments containing the
lesion (T6 to L5) were cut in the horizontal plane. Serial sections (40 μm) were
collected spanning the ventral to dorsal axis. Every four sections were stained for 5HT + axons and the number quantiﬁed. For immunohistochemistry, tissue was
blocked for one hour in PBS with 5% donkey serum and 0.3% Triton X-100, and
then incubated overnight at 4 °C in primary antibodies, diluted in PBS with 5%
donkey serum and 0.3% Triton X-100, followed by treatment with secondary
antibodies (Jackson ImmunoResearch Laboratories Inc. or Invitrogen) for 1–2 h at
room temperature after washing 3 times for 5 min each. Primary antibodies used
were: chicken anti-GFP (1:1000, Abcam ab13970); rabbit anti-RFP (1:500, Abcam
ab34771); mouse anti-NeuN (1:500, Millipore MAB377); rabbit anti-GFAP (1:500,
Dako Z0334); rabbit anti-Olig2 (1:300, Millipore AB9610); rabbit anti-PDGFRβ
(1:500, Thermo Fisher Scientiﬁc MA5-15143); rat anti-CD68 (1:500, BioRad
MCA1957); rat anti-CD31 (1:1:500, BD Biosciences 550274); and goat anti-5-HT
(1:200, Immunostar 20079). The following secondary antibodies were used at 1:400
ﬁnal dilution: 488 Donkey anti-Chicken (703-545-155), 488 Donkey anti-Rabbit
(711-545-152), Biotin Donkey anti-Rabbit (711-066-152), HRP Donkey anti-Rabbit
(715-035-151), Biotin Donkey anti-Rat (712-065-153), HRP Donkey anti-Mouse
(712-035-153), Biotin Donkey anti-Mouse (715-065-151), HRP Donkey antiMouse (715-035-150) from Jackson ImmunoResearch, 568 Donkey anti-Rabbit
(A10042) and 647 Donkey anti-Goat (A-21447) from Thermo Fisher Scientiﬁc
(Invitrogen) and 647 Streptavidin (S-21374) and 568 Streptavidin (S-11226) from
Life Technologies. NeuN, CD31 and PDGFRβ signals were ampliﬁed with a tyramide ampliﬁcation (TSA Cyanine 5 Kit, Perkin Elmer SAT705A001EA). Olig2
and CD68 signals were ampliﬁed with a biotin/streptavidin step between primary
and secondary with biotinylated antibodies raised against the primary antibody’s
host species. For 5-HT stainings, Triton-X100 was raised to 2% during the primary
and washing steps, and primary incubation was performed at room temperature.
After staining, tissue was washed, incubated with DAPI in the last wash step,
adhered to room-temperature charged microscope slides, and mounted with
VECTASHIELD Antifade Mounting Medium (Vector Laboratories, H-1200).
Microscopy and semi-automated cell counting. Fluorescent images were
acquired using a Zeiss LSM710 Confocal Microscope in the IDDRC Imaging Core
of Boston Children’s Hospital. Brightness and contrast of the images were adjusted,
pseudo-colours applied for presentation and images cropped with imageJ (NIH).
When imaging was taken for quantiﬁcation, image capture and processing were
kept constant. 4–5 slides across the dorsal-ventral axis were imaged per spinal cord.
A home-developed Matlab (MathWorks, Inc) algorithm was used for cell
quantiﬁcation. Circle-like cells were identiﬁed using Circular Hough Transform
method. Cell numbers and coordinates in each channel were exported. Then virus
efﬁciencies were quantiﬁed by counting the colocalized signals in different
channels.
Figure 1b background of images were removed using rolling ball background
subtraction method. Then in each image, a segmented line was drawn to cover the
spinal cord area. The intensity values along the segmented line direction were
exported. Intensity values were aligned according to the injury location and
averaged in each serotype.
Figures 3h and 4h images were converted to binary images using a predeﬁned
threshold.
For each section, three to four images were acquired from each sample, which
was repeated across a total of 3 animals and used to create the contour plots. All
images were resized to equal dimensions and a meshgrid was applied to analyse the
number of bright pixels within each square. The density values of each image were
normalized and averaged. A contour plot was drawn to illustrate the axon density
in each section.
Behavioural assessments. Overground motor function was evaluated with a
locomotor open ﬁeld rating scale on the BMS32. fter baseline testing, mice received
systematic administration (i.p.) of CNO. At 1–5 h after CNO injection, BMS
scoring was re-examined in the same set of mice.
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For detailed kinematic analysis, mice were placed in a clear plexiglass runway
(80 cm long, 4 cm wide, and 12 cm high) to assess overground locomotion.
Anatomical landmarks at the iliac crest, hip joint, knee joint, ankle, last toe, and
L1 and L4 vertebrate were highlighted. For each mouse, at least 6 continuous gait
cycles were captured by iPhone with 60 fps. During video acquisition, we focused
on the central area (40 cm) of the plexiglass runway, where each mouse either
walks, drags, and/or steps continuously for about 6–10 gaits. However, we cannot
rule out errors as a result of quickly moving mice and modest speed of the iPhone
camera. If the hindlimbs did not move, we used the forelimbs to determine the gait.
For each mouse, we recorded at least 3 trials. The videos were chosen for further
analysis based on the following criteria: (1) Continuous movement in the recording
region; (2). Forward movement without head rotation. These videos were analysed
by using DeepLabCut65 to trace the joints automatically. The kinematics were then
analysed blindly and a stick view of hindlimb movements was drawn by MATLAB.
Different individuals collected behavioural data and performed kinematic analyses.
For the supplementary videos, mice without highlighted anatomical landmarks
moved freely along the edge of a table while videos were recorded from a side view.
For analysing gait cycle, including angular excursions, oscillation of hip, knee,
and ankle, and the horizontal hindlimb excursions, we followed the procedure
described in Alluin et al.66,67, and Zorner et al.68. Intralimb coordination was
analysed with the method described in Courtine et al.20,63.
For quantiﬁcation of spasms of Vglut2 mice (Fig. 3), mice were placed on a
transparent surface and videotaped from below for 3 h after CNO application.
Spastic episodes were manually counted over a 5 min period at 60 min post CNO
treatment. To quantify spastic events after lumbar injection (Supplementary
Fig. 9e), mice were observed on an open surface and assessed using a mean spasmfrequency score ranging from 0 (on spasms on most days) to 4 (>10 spontaneous
spasms/hour)38.
For noxious sensory behaviour tests, mice were ﬁrst habituated to chambers
(7.5 × 7.5 × 15 cm) for 60 min on 3 consecutive days. On the third day, animals
were tested before and after CNO application (1, 2, 3, 4, 7, and 24 h) for their
response to the following stimuli: pinprick or laser heat. For pinprick, a 30 G needle
was applied ten times to the plantar surface of the hindlimb paw. A positive
response was measured as stimuli-induced hindlimb movement including
ﬂinching, guarding, or jumping behaviour, which was often observed in parallel
with spastic activity. For laser heat, a 447 nm laser beam, up to 200 mW, was also
applied to the plantar surface of the hindlimb paw and the average time to paw
withdrawal was calculated from three consecutive trials. Animals were returned to
their home cage between measurements at 7 and 24 h.

EMG recording. At indicated time points after T8 crush surgery, anesthetized mice
underwent implantation of home-made bipolar electrodes into selected hindlimb
muscles. Stainless steel electrodes (793200, A-M Systems Inc.) were led by 30 gauge
needles and inserted into the mid-belly of gluteus maximus (GM), vastus lateralis
(VL), semitendinosus (ST), tibialis anterior (TA), and lateral gastrocnemius (GS) of
one hindlimb. A common ground wire was positioned subcutaneously in the neckshoulder area. Wires were routed subcutaneously through the back to a connector
securely cemented to the skull. Mice were allowed 7 days of recovery before subjected to behavioural assessment and EMG recording. EMG signals were acquired
using differential AC ampliﬁer (1700, A-M Systems Inc.) with 10–1000 Hz bandwidth ﬁlters, sampled at 4 kHz using a digitizer (PowerLab 16/35, ADInstruments
Inc.), and analysed using LabChart 8 (ADInstruments Inc.). Acquired EMG signals
and video recordings were synchronized using a digital light signal captured in
both and to which the timeline was zeroed. CNO was administrated (i.p.) after 10
to 15 min of stable baseline recording. To record EMG signals during ground
walking, mice were allowed to walk freely in an enclosed straight plexiglass runway
while recording. To quantify EMG signals during spastic episodes, signals were
rectiﬁed where 20-s episodes without obvious electromagnetic interference or
movement artifacts from either baseline or 15 min after CNO were selected, and
the area under curve (AUC) was calculated by integrating data points with sample
interval. EMG recordings after CNO were normalized to the average baseline to
eliminate variations from individual muscles.

Quantiﬁcation, statistics and reproducibility. Prior to statistical analysis, data
were analysed by ESD (extreme studentized deviate) test. Assumptions (normality,
equal variance) were tested by SAS 9.4 before applying parametric analyses. Paired,
two-tailed Student’s t test or sign test was performed for comparison of the same
group of mice before and after CNO treatment according to normality test result.
Two sample t test or Wilcoxon rank sum was used for between group pairwise
comparisons according to normality test result. The rest of the data were analysed
using one-way or two-way ANOVA with or without repeated measures depending
on the appropriated design. Multiple comparison procedures were carried out to
identify speciﬁc between-group differences using Bonferroni’s post hoc. Error bars
in all ﬁgures represent mean ± SD. Differences were considered statistically signiﬁcant at p value below 0.05. *, **, ***, p < 0.05, 0.01, 0.001, respectively. All data
were analysed using SAS 9.4 and GraphPad Prism 8.0. In all images the number of
mice used is speciﬁed in the ﬁgure legend.
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Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
The data that support the ﬁndings of this study are available from the corresponding
author upon reasonable request. Source data are provided with this paper.

Code availability
All custom codes are provided with this paper.
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